The influence of pharmacy and pharmacist characteristics on the secondary prevention of cardiovascular disease

International Journal of Clinical Pharmacy

Volumn 37, Issue 5, 2015, Pages 834-843

  Puspitasari, Hanni Prihhastuti ^a,b   Aslani, Parisa ^a   Krass, Ines ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b AIRLANGGA UNIVERSITY   (Indonesia)

Author keywords

Australia; Cardiovascular disease; Chronic disease management; Community setting; Pharmaceutical Care; Pharmacy services

Indexed keywords

ACCREDITATION; ADULT; ARTICLE; AUSTRALIAN; CARDIOVASCULAR DISEASE; COMMUNITY; FEMALE; HEALTH CARE QUALITY; HUMAN; MALE; MEDICAL DOCUMENTATION; PHARMACIST; PHARMACY; PRIORITY JOURNAL; RESOURCE MANAGEMENT; SECONDARY PREVENTION; AUSTRALIA; CARDIOVASCULAR DISEASES; HEALTH PERSONNEL ATTITUDE; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PROCEDURES; PROFESSIONAL STANDARD; PSYCHOLOGY;

ADULT; ATTITUDE OF HEALTH PERSONNEL; AUSTRALIA; CARDIOVASCULAR DISEASES; COMMUNITY PHARMACY SERVICES; FEMALE; HUMANS; MALE; MIDDLE AGED; PHARMACISTS; PROFESSIONAL ROLE; SECONDARY PREVENTION;

EID: 84943197619     PISSN: 22107703     EISSN: 22107711     Source Type: Journal    
DOI: 10.1007/s11096-015-0127-y     Document Type: Article

References (41)

1. Hatah E, Braund R, Duffull S, Tordoff J. General practitioners’ perceptions of pharmacists new services in New Zealand. Int J Clin Pharm. 2012;34(2):364–73.
2. Cavaco AM, Dias JPS, Bates IP. Consumers’ perceptions of community pharmacy in Portugal: a qualitative exploratory study. Pharm World Sci. 2005;27(1):54–60.
3. Ruston A. Achieving re-professionalisation: factors that influence the adoption of an ‘extended role’ by community pharmacists. A national survey. J Soc Adm Pharm. 2001;18(3):103–10.
4. Norris P. Extended roles for pharmacists in New Zealand pharmacies: What kinds of pharmacies and pharmacists are involved? J Soc Adm Pharm. 2003;20(4):125–31.
5. Doucette WR, Kreling DH, Schommer JC, Gaither CA, Mott DA, Pedersen CA. Evaluation of community pharmacy service mix: evidence from the 2004 National Pharmacist Workforce Study. J Am Pharm Assoc. 2006;46(3):348–55.
6. Berbatis CG, Sunderland VB, Joyce A, Bulsara MK, Mills C. Enhanced pharmacy services, barriers and facilitators in Australia’s community pharmacies: Australia’s National Pharmacy Database Project. Int J Pharm Pract. 2007;15(3):185–91.
7. Latif A, Boardman HF. Community pharmacists’ attitudes towards medicines use reviews and factors affecting the numbers performed. Pharm World Sci. 2008;30(5):536–43.
8. Blake KB, Madhavan SS. Perceived barriers to provision of medication therapy management services (MTMS) and the likelihood of a pharmacist to work in a pharmacy that provides MTMS. Ann Pharmacother. 2010;44(3):424–31.
9. Gadkari AS, Mott DA, Kreling DH, Bonnarens JK. Pharmacy characteristics associated with the provision of drug therapy services in nonmetropolitan community pharmacies. J Rural Health. 2009;25(3):290–5.
10. Haag JD, Stratton TP. Patient care services in rural Minnesota community pharmacies. J Am Pharm Assoc. 2010;50(4):508–16.
11. Schoen C, Osborn R, Huynh PT, Doty M, Davis K, Zapert K, et al. Primary care and health system performance: adults’ experiences in five countries. Health Aff. 2004;W4:487–503.
12. Australian Government Department of Health and the Pharmacy Guild of Australia. The fifth community pharmacy agreement between the Commonwealth of Australia and the Pharmacy Guild of Australia. 2010 [cited 2014 Aug 28]. http://www.health.gov.au/internet/main/publishing.nsf/Content/fifth-community-pharmacy-agreement.
13. Australian Government Department of Health and the Pharmacy Guild of Australia. Programme specific guidelines: pharmacy practice incentives (PPI). 2014 [cited 2014 Aug 28]. http://5cpa.com.au/programs/pharmacy-practice-incentives/.
14. Australian Government Department of Health and the Pharmacy Guild of Australia. 5CPA general terms and conditions. 2014 [cited 2014 Aug 28]. http://5cpa.com.au/programs/pharmacy-practice-incentives/.
15. Pharmaceutical Society of Australia. Guidelines for pharmacists providing home medicines review (HMR) services. Canberra: PSA; 2011 [cited 2013 Aug 18]. http://www.psa.org.au/download/practice-guidelines/home-medicines-review-services.pdf.
16. Pharmaceutical Society of Australia. Guidelines for pharmacists providing medicines uses review (MedsCheck) and diabetes medication management (Diabetes MedsCheck) services. Canberra: PSA; 2012 [cited 2013 Aug 18]. http://www.psa.org.au/download/guidelines/3612-medscheck-guidelines-c.pdf.
17. Puspitasari HP, Aslani P, Krass I. Australian community pharmacists’ awareness and practice in supporting secondary prevention of cardiovascular disease. Int J Clin Pharm. 2013;35(6):1218–28.
18. Puspitasari HP, Aslani P, Krass I. Challenges in the care of clients with established cardiovascular disease: lessons learned from Australian community pharmacists. PLoS One. 2014;9(11):e113337.
19. Rao PSRS. Sampling methodologies with applications. Boca Raton: Chapman & Hall/CRC; 2000. ISBN 1-58488-214-X.
20. Oladapo AO, Rascati KL. Review of survey articles regarding medication therapy management (MTM) services/programs in the United States. J Pharm Pract. 2012;25(4):457–70.
21. Australian Government Department of Health. Australian standard geographic classification—remoteness area (ASGC-RA). Canberra: Department of Health; 2001 [updated 2007 Nov 8; cited 2014 Jan 16]. http://www.doctorconnect.gov.au/internet/otd/publishing.nsf/Content/locator.
22. Van C, Costa D, Mitchell B, Abbott P, Krass I. Development and initial validation of the pharmacist frequency of interprofessional collaboration instrument (FICI-P) in primary care. Res Soc Adm Pharm. 2012;8(5):397–407.
23. Van C, Costa D, Abbott P, Mitchell B, Krass I. Community pharmacist attitudes towards collaboration with general practitioners: development and validation of a measure and a model. BMC Health Serv Res. 2012;12:320.
24. Doucette WR, Nevins JC, Gaither C, Kreling DH, Mott DA, Pedersen CA, et al. Organizational factors influencing pharmacy practice change. Res Soc Adm Pharm. 2012;8(4):274–84.
25. Ho R. Handbook of univariate and multivariate data analysis and interpretation with SPSS. Boca Raton: Chapman & Hall/CRC; 2006. ISBN 1-58488-602-1.
26. Miller LE, Smith KL. Handling nonresponse issues. J Ext. 1983;21(5):45–50.
27. Australian Institute of Health and Welfare. Allied health workforce 2012. National health workforce series no. 5. Cat. no. HWL 51. Canberra: Australian Institute of Health and Welfare; 2013.
28. Roberts AS, Benrimoj SI, Chen TF, Williams KA, Aslani P. Practice change in community pharmacy: quantification of facilitators. Ann Pharmacother. 2008;42(6):861–8.
29. Feletto E, Wilson LK, Roberts AS, Benrimoj SI. Building capacity to implement cognitive pharmaceutical services: quantifying the needs of community pharmacies. Res Soc Adm Pharm. 2010;6(3):163–73.
30. Tordoff J, Chang SY, Norris PT. Community pharmacists’ perceptions of services that benefit older people in New Zealand. Int J Clin Pharm. 2012;34(2):342–50.
31. Rosenthal M, Grindrod KA, Lynd L, Marra CA, Bougher D, Wilgosh C, et al. Pharmacists’ perspectives on providing chronic disease management services in the community—part II: development and implementation of services. Can Pharm J. 2009;142(6):284–8.
32. Ibrahim A, Scott J. Community pharmacists in Khartoum State, Sudan: their current roles and perspectives on pharmaceutical care implementation. Int J Clin Pharm. 2013;35(2):236–43.
33. Willink DP, Isetts BJ. Becoming ‘indispensable’: developing innovative community pharmacy practices. J Am Pharm Assoc. 2005;45(3):376–89.
34. AbuRuz S, Al-Ghazawi M, Snyder A. Pharmaceutical care in a community-based practice setting in Jordan: Where are we now with our attitudes and perceived barriers? Int J Pharm Pract. 2012;20(2):71–9.
35. Urbonas G, Jakusovaite I, Savickas A. Pharmacy specialists’ attitudes toward pharmaceutical service quality at community pharmacies. Medicina (Kaunas). 2010;46(10):686–92.
36. Bryant LJM, Coster G, Gamble GD, McCormick RN. General practitioners’ and pharmacists’ perceptions of the role of community pharmacists in delivering clinical services. Res Soc Adm Pharm. 2009;5(4):347–62.
37. Herbert KE, Urmie JM, Newland BA, Farris KB. Prediction of pharmacist intention to provide Medicare medication therapy management services using the theory of planned behavior. Res Soc Adm Pharm. 2006;2(3):299–314.
38. Gastelurrutia MA, Benrimoj SI, Castrillon CC, de Amezua MJC, Fernandez-Llimos F, Faus MJ. Facilitators for practice change in Spanish community pharmacy. Pharm World Sci. 2009;31(1):32–9.
39. Grindrod KA, Rosenthal M, Lynd L, Marra CA, Bougher D, Wilgosh C, et al. Pharmacists’ perspectives on providing chronic disease management services in the community—part I: current practice environment. Can Pharm J. 2009;142(5):234–9.
40. Helper CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47(3):533–43.
41. Grimes T, Duggan C, Gallagher P, Strawbridge J. Care of the stroke patient—communication between the community pharmacist and prescribers in the Republic of Ireland. Pharm World Sci. 2009;31(6):648–55.